Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
Nelson Leung(WinnMed), Robert A. Kyle(Mayo Clinic), Frank Bridoux(Université de Poitiers), Kevin Song(Vancouver General Hospital), Colin A. Hutchison(NIHR Surgical Reconstruction and Microbiology Research Centre), Jean-Paul Fermand(Hôpital Saint-Louis), Angela Dispenzieri(Mayo Clinic), Samih H. Nasr(Mayo Clinic), Paul Cockwell(University Hospitals Birmingham NHS Foundation Trust)
Cited by 543
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k